Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mesocricetus auratus skin, commonly processed as hamster epithelium allergen extract, is a biological product used for the diagnosis and treatment of Type I hypersensitivity reactions to hamsters. In diagnostic settings, the extract is utilized in skin prick testing or intradermal testing to elicit a localized wheal-and-flare response, indicating the presence of allergen-specific IgE antibodies on the surface of mast cells. Therapeutically, it is employed in allergen immunotherapy (AIT), where it is administered subcutaneously in escalating doses to induce immunological tolerance. This desensitization process aims to reduce the clinical symptoms of allergic rhinitis, asthma, and conjunctivitis by modulating the T-cell response and increasing the production of regulatory T cells and IgG4 antibodies. The product is derived from the skin and hair of the Golden (Syrian) hamster and is regulated as a biological drug by agencies such as the FDA's Center for Biologics Evaluation and Research (CBER).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hamster epithelium allergen extract.